What is TB-500
For many patients, the benefits can be life-changing: Improved blood sugar control Reduced A1C levels Significant weight reduction Lower risk of obesity-related complications However, long-term affordability remains a real concern
GLP-1RAs appear to offer a potential dual therapeutic advantage, simultaneously targeting metabolic dysfunction and immune-mediated inflammation, thereby representing a potentially promising strategy in the management of early-stage PsA early PsA, although robust clinical evidence in this setting is currently lacking
& Ma, T
GLP-1 medications, or glucagon-like peptide-1 receptor agonists, treat type 2 diabetes and, in some cases, obesity
While the name of this condition is complex, heres how it breaks down: Non-arteritic: Doesnt involve inflammation of the arteries, unlike arteritic anterior ischemic optic neuropathy (AAION)